Alzamend Neuro, Inc. (NASDAQ:ALZN)
| Market Cap | 5.08M-51.8% |
| Revenue (ttm) | 0 |
| Net Income | -9.10M-45.7% |
| EPS | -2.30+74.5% |
| Shares Out | 4.83M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,684.565 |
| Open | 1.32 |
| Previous Close | 1.37 |
| Day's Range | 1.22 - 1.33 |
| 52-Week Range | 0.84 - 2.68 |
| Beta | 0.19 |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | Dec 8, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About ALZN
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$ALZN stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in ALZN holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ALZN's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ALZN Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New ALZN patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ALZN from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in ALZN
| ETF | Est. Holding Size |
|---|---|
| VXFVanguard Extended Market ETF | $12.01K |
Estimated from each fund’s disclosed top holdings × AUM
ALZN Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from ALZN’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score